Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether hepatic de novo lipogenesis (DNL) in response to the ingestion of a mixture of glucose and fructose is greater in South Asians compared to controls (C...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The Rogosin Institute
Collaborators
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07224321 · Type 1 Diabetes Mellitus
NCT01399385 · Healthy, Obesity, and more
NCT07395050 · Stage 3 Type 1 Diabetes
The Rogosin Institute
New York, New York
Weill Cornell Medical College Clinical and Translational Science Center (CTSC)
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions